Singapore markets open in 3 hours 51 minutes

ORIC Pharmaceuticals, Inc. (ORIC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.95+0.93 (+8.44%)
At close: 04:00PM EST
11.95 0.00 (0.00%)
After hours: 04:01PM EST
Full screen
Trade prices are not sourced from all markets
Previous close11.02
Bid11.99 x 800
Ask12.05 x 800
Day's range11.05 - 12.06
52-week range4.09 - 13.42
Avg. volume416,590
Market cap801.27M
Beta (5Y monthly)0.99
PE ratio (TTM)N/A
EPS (TTM)-1.98
Earnings date14 Mar 2024 - 18 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est16.14
  • GlobeNewswire

    ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit

    SOUTH SAN FRANCISCO and SAN DIEGO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a fireside chat at the Citi 2024 Virtual Oncology Leadership Summit on Wednesday, February 21, 2024, at 3:00 p.m. ET. A live webcast of the discussion will be available through the investor section of the company’s web


    ORIC Pharmaceuticals CEO Jacob Chacko Sells 40,000 Shares

    On February 7, 2024, Jacob Chacko, the President and CEO of ORIC Pharmaceuticals Inc (NASDAQ:ORIC), executed a sale of 40,000 shares of the company, according to a recent SEC Filing.

  • Zacks

    Recent Price Trend in Oric Pharmaceuticals, Inc. (ORIC) is Your Friend, Here's Why

    Oric Pharmaceuticals, Inc. (ORIC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.